Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Core EBITDA(x) 8.728.867.2123.4711.72

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 8.72 based on Mar2023 Consolidated results.
Year EV/Core EBITDA
Mar20238.72
Mar20228.86
Mar20217.21
Mar202023.47
Mar201911.72

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2023 8.72
-1.58
Mar2022 8.86
22.88
Mar2021 7.21
-69.28
Mar2020 23.47
100.26
Mar2019 11.72 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹160.5 Cr -1.7% -1.3% 16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,071.0 Cr 0.2% -6.1% 55.7% Stock Analytics
CIPLA ₹111,808.0 Cr -2.5% -5.1% 48.6% Stock Analytics
DIVIS LABORATORIES ₹104,300.0 Cr -0.9% 5% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,202.0 Cr 1.8% 2.2% 88.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,035.0 Cr -3.7% -1.4% 26% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1.7%

-1.3%

16.9%

SENSEX

-1.4%

-0.6%

20.1%


You may also like the below Video Courses